Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Get Free Report) has received a consensus recommendation of “Hold” from the nine research firms that are currently covering the stock, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $21.1111.
A number of research firms have weighed in on SBRA. Cantor Fitzgerald started coverage on Sabra Healthcare REIT in a report on Wednesday, October 1st. They set a “neutral” rating and a $20.00 target price on the stock. Wells Fargo & Company upped their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. Truist Financial raised their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “hold” rating in a research report on Tuesday. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, October 8th. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $22.00 price target on shares of Sabra Healthcare REIT in a research note on Monday, December 15th.
View Our Latest Stock Analysis on Sabra Healthcare REIT
Sabra Healthcare REIT Stock Down 1.5%
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last announced its earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.01. Sabra Healthcare REIT had a net margin of 23.50% and a return on equity of 6.38%. The firm had revenue of $190.04 million for the quarter, compared to analyst estimates of $193.44 million. During the same quarter in the previous year, the firm posted $0.37 EPS. The company’s revenue for the quarter was up 6.7% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. Equities analysts expect that Sabra Healthcare REIT will post 1.45 earnings per share for the current year.
Sabra Healthcare REIT Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, November 28th. Stockholders of record on Monday, November 17th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 6.3%. The ex-dividend date was Monday, November 17th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 166.67%.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Focus Partners Wealth grew its stake in shares of Sabra Healthcare REIT by 11.4% in the first quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock worth $404,000 after acquiring an additional 2,375 shares during the last quarter. Strs Ohio bought a new position in Sabra Healthcare REIT in the 1st quarter worth about $777,000. Parallel Advisors LLC boosted its stake in Sabra Healthcare REIT by 7.0% in the 2nd quarter. Parallel Advisors LLC now owns 17,477 shares of the real estate investment trust’s stock worth $322,000 after purchasing an additional 1,146 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its position in Sabra Healthcare REIT by 23.6% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 12,748 shares of the real estate investment trust’s stock valued at $237,000 after purchasing an additional 2,433 shares during the last quarter. Finally, Exchange Traded Concepts LLC increased its stake in Sabra Healthcare REIT by 2.0% during the 2nd quarter. Exchange Traded Concepts LLC now owns 48,718 shares of the real estate investment trust’s stock valued at $898,000 after purchasing an additional 936 shares in the last quarter. Institutional investors own 99.40% of the company’s stock.
Sabra Healthcare REIT Company Profile
Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.
Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.
See Also
- Five stocks we like better than Sabra Healthcare REIT
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
